Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients Receiving Daclatasvir (DCV) Trio Therapy
Clinical trial NCT03071133 · COMPLETED
Trial details
- NCT number
- NCT03071133
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-01-01
- Primary completion
- 2019-01-08
- Enrollment
- 344
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.